Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dialysis01:27

Dialysis

1.2K
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.2K
Dialysis01:15

Dialysis

1.6K
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.6K
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

297
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
297
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

271
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
271
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

398
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
398
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

758
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
758

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medication Burden and Regimen Complexity Among Dialysis Patients from 2003 to 2024.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2025.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2025
Same author

Dialysate Sodium Lowering in Maintenance Hemodialysis: A Randomized Clinical Trial.

Clinical journal of the American Society of Nephrology : CJASN·2024
Same author

Association of Longitudinal Urinary Metabolic Biomarkers With ADPKD Severity and Response to Metformin in TAME-PKD Clinical Trial Participants.

Kidney international reports·2023
Same author

Seroresponse to Inactivated and Recombinant Influenza Vaccines Among Maintenance Hemodialysis Patients.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2022
Same author

Assessing Risk of Progression in ADPKD.

Clinical journal of the American Society of Nephrology : CJASN·2021

Related Experiment Video

Updated: Jan 18, 2026

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
09:07

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Published on: January 20, 2017

10.5K

Influenza in dialysis patients: an opportunity to decrease mortality?

Dana C Miskulin1

  • 1Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA.

Current Opinion in Nephrology and Hypertension
|October 1, 2019
PubMed
Summary

High-dose influenza vaccines are recommended for dialysis patients, potentially offering better protection. Delaying vaccination until late October to mid-November may further enhance vaccine efficacy in this vulnerable population.

More Related Videos

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.1K
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.9K

Related Experiment Videos

Last Updated: Jan 18, 2026

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
09:07

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Published on: January 20, 2017

10.5K
A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.1K
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.9K

Area of Science:

  • Nephrology
  • Immunology
  • Infectious Diseases

Background:

  • Influenza poses a significant health risk, leading to high morbidity in dialysis patients.
  • Current evidence on influenza vaccination in dialysis patients is limited, with no randomized clinical trials available.

Purpose of the Study:

  • To review current evidence and provide recommendations for influenza vaccination and treatment in dialysis patients.
  • To evaluate the efficacy of high-dose versus standard-dose influenza vaccines.
  • To assess the role of novel antiviral treatments like baloxavir.

Main Methods:

  • Review of a recent meta-analysis on high-dose vaccines in the elderly.
  • Analysis of observational studies comparing vaccine doses in dialysis patients.
  • Inclusion of a simulation study on optimal vaccination timing.
  • Consideration of a phase 3 trial for baloxavir efficacy.

Main Results:

  • High-dose vaccines showed reduced infections, hospitalizations, and deaths in the elderly.
  • Observational studies in dialysis patients yielded mixed results regarding high-dose vaccine benefits.
  • Vaccine efficacy may increase with later administration in populations with premature antibody waning.
  • Baloxavir demonstrated faster virus titer decline but similar symptom resolution compared to oseltamivir in low-risk patients.

Conclusions:

  • Recommend high-dose influenza vaccine for all dialysis patients, extending evidence from the elderly.
  • Suggest delaying vaccination until late October to mid-November to potentially enhance efficacy.
  • Consider baloxavir premature for treatment in dialysis patients pending further trial data.